In our “meet the VC” series, Delano is talking to local venture capitalists to discover their firms and their perspectives on the field. In this edition, Fabienne Roussel introduces us to Vesalius Biocapital and discusses healthtech in Luxembourg.
/PRNewswire/ Vesalius Biocapital, the specialist life sciences venture capital investor, announces the first close of its fourth fund, Vesalius Biocapital.